Optimized synthesis of therapeutic MK2 inhibitor cell penetrating peptide: reduction in synthesis time using parallel automated synthesis

 

 

Andrew Kennedy, James P. Cain, Daniel Martinez, and Cyf Ramos-Colón
Protein Technologies, Inc. 4675 South Coach Drive, Tucson, Arizona, 85714, U.S.A.

 

 

Please fIll in the form to download the poster